GTCM
COGT icon

Gyon Technologies Capital Management’s Cogent Biosciences COGT Stock Holding History

Gyon Technologies Capital Management’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,748
Closed -$78K – 104
2022
Q4 		$78K Sell
6,748
-16,066
-70% -$199K 0.03% 372
2022
Q3 		$340K Buy
+22,814
New +$313K 0.11% 193

Other funds holding COGT

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Gyon Technologies Capital Management's COGT Position: Q1 2023 in Review

Gyon Technologies Capital Management sold out of Cogent Biosciences (COGT) in Q1 2023, closing a stake of 6,748 shares — an estimated $78K sold.

Gyon Technologies Capital Management first reported a position in COGT in Q3 2022 and held it in 2 quarters. The position peaked at $340K in Q3 2022. 136 funds tracked by Wall St. Rank hold COGT as of Q1 2023.

  • Gyon Technologies Capital Management reported no remaining Cogent Biosciences position as of Q1 2023 after selling out during the quarter.
  • Gyon Technologies Capital Management sold 6,748 Cogent Biosciences shares in Q1 2023, an estimated $78K.
  • Gyon Technologies Capital Management first reported a position in Cogent Biosciences in Q3 2022 and held it in 2 quarters.
  • Gyon Technologies Capital Management's Cogent Biosciences position peaked at $340K in Q3 2022.
  • 136 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2023.

Based on Gyon Technologies Capital Management's 13F filing for Q1 2023.